• Login
    View Item 
    •   Home
    • Yale Law School Journals
    • Yale Journal of Health Policy, Law, and Ethics
    • View Item
    •   Home
    • Yale Law School Journals
    • Yale Journal of Health Policy, Law, and Ethics
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of openYLSCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Non-Beneficial Pediatric Research and the Best Interests Standard: A Legal and Ethical Reconciliation

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    11_8YaleJHealthPolyL_Ethics359 ...
    Size:
    3.849Mb
    Format:
    PDF
    Download
    Author
    Litton, Paul
    
    Metadata
    Show full item record
    URI
    http://hdl.handle.net/20.500.13051/6094
    Abstract
    In 1966, Henry Beecher, a professor at Harvard Medical School, published an article in the New England Journal of Medicine describing twenty-two cases of unethical medical research, some of which involved children. In the infamous Willowbrook study, for example, researchers deliberately exposed children who were wards in a state facility to hepatitis to study preventive measures. Public attention to research tragedies led to the passage of federal regulations governing human subjects research, including special protections for children. The regulations restricted the participation of children in research, and, in that sense, they have protected children. However, this effort to protect children "may partly explain the underfunding and understudy of... health issues unique to children" that followed. Consequently, the vast majority of medications prescribed to children today have not been adequately studied in pediatric populations. Since the late 1990s, deploying an array of carrots and sticks, the federal government has sought to increase pediatric research, particularly with respect to pharmaceuticals, to address our lack of knowledge regarding the safety and efficacy of pediatric therapies. Its efforts have worked. Between 1990 and 1997, researchers completed eleven pediatric studies of marketed drugs; since 1997, the Food and Drug Administration (FDA) has requested approximately 800 studies involving 45,000 children in clinical trials. Pediatric research will continue to expand as the President recently signed into law measures to encourage pediatric research regarding medical devices.
    Collections
    Yale Journal of Health Policy, Law, and Ethics

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.